|
| Press Releases |
|
 |
|
| Thursday, January 2, 2025 |
|
|
SPRG Steps Confidently into its 30th Year of Development |
| Strategic Public Relations Group ("SPRG" or the "Group") proudly announces its transition into its 30th year of development - a significant milestone in its business journey. To celebrate, the Group will organise various events and activities, including a 30th Anniversary Logo Design Contest that was held at the end of 2024. The logo with the 30 and globe will be used in various SPRG materials in 2025 and represent the Group's commitment to delivering the best services to clients via its global reach and international talent pool. more info >> |
|
|
纵横公关集团成立30周年 昂首迈向璀璨新里程 |
| 纵横公共关系顾问集团 (简称「纵横公关集团」或「集团」) 今日欣然宣布正式迈入集团成立30周年的辉煌时刻。为纪念这一里程碑，集团推出各种活动以示庆祝，其中包括已于2024年底圆满落幕的30周年标志设计比赛。 more info >> |
|
|
縱橫公關集團成立30周年 昂首邁向璀璨新里程 |
| 縱橫公共關係顧問集團 (簡稱「縱橫公關集團」或「集團」) 今日欣然宣佈正式邁入集團成立30周年的輝煌時刻。為紀念這一里程碑，集團推出各種活動以示慶祝，其中包括已於2024年底圓滿落幕的30周年標誌設計比賽。 more info >> |
|
| Monday, January 4, 2021 |
|
|
纵横公关集团无惧逆风砥砺前行取得理想进展 |
| 纵横公共关系顾问集团 (「纵横公关集团」或「集团」)在2020年疫情肆虐下依然稳步发展、获得理想进展，这归功于集团在艰难时刻依然坚持为客户提供最专业和卓越的服务，同时集团信守回馈社会的承诺，持续肩负着企业公民责任。 more info >> |
|
|
縱橫公關集團無懼逆風砥礪前行取得理想進展 |
| 縱橫公共關係顧問集團 (「縱橫公關集團」或「集團」)在2020年疫情肆虐下依然穩步發展、獲得理想進展，這歸功於集團在艱難時刻依然堅持為客戶提供最專業和卓越的服務，同時集團信守回饋社會的承諾，持續肩負著企業公民責任。 more info >> |
|
|
SPRG Achieves Progress On Various Fronts Despite Toughest Year In Decades |
| Strategic Public Relations Group ("SPRG" or the "Group") has finished 2020 in fine shape despite the many challenges the pandemic posed during the past year. more info >> |
|
| Friday, November 1, 2019 |
|
|
纵横公关集团缔造新股上市传讯市场纪录 |
| 纵横公共关系顾问集团(「纵横公关集团」或「集团」)刚于14个交易日内完成7个上市传讯项目，而今日在香港联合交易所主板上市的ESR Cayman Ltd. (「ESR」;股份代号: 1821)正好标志着集团成立以来的第455个新上市传讯项目，刷新香港新上市传讯市场的纪录，同时进一步突显了纵横公关集团在香港财经传讯行业的领导地位。 more info >> |
|
|
縱橫公關集團締造新股上市傳訊市場紀錄 |
| 縱橫公共關係顧問集團（「縱橫公關集團」或「集團」）剛於14個交易日內完成7個上市傳訊項目，而今日在香港聯合交易所主板上市的ESR Cayman Ltd.（「ESR」；股份代號 ：1821）正好標誌著集團成立以來的第455個新上市傳訊項目，刷新香港新上市傳訊市場的紀錄，同時又增加突顯了縱橫公關集團在香港財經傳訊行業的領導地位。 more info >> |
|
|
SPRG Caps Record Number of Hong Kong IPO Communications Campaigns |
| Strategic Public Relations Group ("SPRG" or the "Group") has completed seven IPO communication campaigns in 14 trading days, including that for ESR Cayman Ltd. ("ESR"; SEHK Stock Code: 1821) listed on the mainboard of HKEX today. It is also the 455th IPO project undertaken by the Group since its inception in 1995 more info >> |
|
| Tuesday, May 7, 2019 |
|
|
纵横公关集团投资澳洲Financial & Corporate Relations Pty Limited |
纵横公共关系顾问集团 (「纵横公关集团」或「集团」)宣布收购澳洲著名投资者关系及财经传讯顾问公司Financial & Corporate Relations Pty Limited (「FCR」)百分之二十股权，将集团业务覆盖范围进一步扩展至亚太区。
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Set at the Osaka-Kansai Expo venue! Detailed program announced for the "OSAKA JAPAN SDGs Forum"
Jul 29, 2025 14:30 JST
|
|
|
GTJAI Achieved 'Carbon Neutrality' at Operational Level for the Third Consecutive Year
Jul 29, 2025 13:15 HKT/SGT
|
|
|
Unitree Races Toward IPO as Robot Applications Accelerate: Shoucheng Holdings Unlocks Dual-Engine Gains
Jul 29, 2025 11:30 HKT/SGT
|
|
|
宇樹衝刺IPO、機械人應用加速落地：首程控股雙輪驅動兌現紅利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
宇树冲刺IPO、机器人应用加速落地：首程控股双轮驱动兑现红利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
國泰君安國際連續第三年實現營運層面「碳中和」
Jul 29, 2025 11:19 HKT/SGT
|
|
|
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Jul 29, 2025 9:01 JST
|
|
|
GEN 與 Sulfateq BV 公佈治療阿茲海默症及其他神經退化性疾病的候選藥物 SUL-238 的第一階段臨床試驗正面結果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
GEN 与 Sulfateq BV 公布治疗阿尔茨海默病及其他神经退行性疾病的候选药物 SUL-238 的第一阶段临床试验积极结果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 05:00: JST
|
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 04:00 HKT/SGT
|
|
|
HKTDC boosts Hong Kong's competitive edge in high-value services
Jul 28, 2025 23:30 HKT/SGT
|
|
|
Intelligent Tech Unlocks the Future - Connecting the World, CITIC Telecom Unveils Future-ready Solutions at WAIC 2025
Jul 28, 2025 23:16 HKT/SGT
|
|
|
Phoenitron Grants Share Options and Sets HK$75 Million Profit Target for First Three Quarters
Jul 28, 2025 23:08 HKT/SGT
|
|
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Jul 28, 2025 21:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
